Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas
- 22 August 1995
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 64 (4) , 280-285
- https://doi.org/10.1002/ijc.2910640412
Abstract
The AKT2 gene is one of the human homologues of v‐akt, the transduced oncogene of the AKT8 virus, which induces lymphomas in mice. In previous studies, AKT2, which codes for a serine‐threonine protein kinase, was shown to be amplified and overexpressed in some human ovarian carcinoma cell lines and amplified in primary tumors of the ovary. To confirm and extend these findings, we conducted a large‐scale, multicenter study of AKT2 alterations in ovarian and breast cancer. Southern‐blot analysis demonstrated AKT2 amplification in 16 of 132 (12.1%) ovarian carcinomas and in 3 of 106 (2.8%) breast carcinomas. No AKT2 alteration was detected in 24 benign or borderline tumors. Northern‐blot analysis revealed overexpression of AKT2 in 3 of 25 fresh ovarian carcinomas which were negative for AKT2 amplification. The difference in the incidence of AKT2 alterations in ovarian and breast cancer suggests a specific role for this gene in ovarian oncogenesis. No significant association was found between AKT2 amplification and amplification of the proto‐oncogenes MYC and ERBB2, suggesting that amplification of AKT2 defines an independent subset of breast and ovarian cancers. Ovarian cancer patients with AKT2 alterations appear to have a poor prognosis. Amplification of AKT2 was especially frequent in undifferentiated tumors (4 of 8, p = 0.019), suggesting that AKT2 alterations may be associated with tumor aggressiveness.Keywords
This publication has 20 references indexed in Scilit:
- Association between High Levels of Expression of the TRK Gene and Favorable Outcome in Human NeuroblastomaNew England Journal of Medicine, 1993
- Chromosome aberrations in 35 primary ovarian carcinomasGenes, Chromosomes and Cancer, 1992
- Report of the committee on the genetic constitution of chromosome 19Cytogenetic and Genome Research, 1991
- Origins of human cancer revisitedCell, 1990
- c-myc amplification in ovarian cancerGynecologic Oncology, 1990
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989
- The human myc gene family: structure and activity of L-myc and an L-myc pseudogene.Genes & Development, 1987
- myc family oncogene amplification in tumor cell lines established from small cell lung cancer patients and its relationship to clinical status and course.Journal of Clinical Investigation, 1987
- Amplification of N- myc in Untreated Human Neuroblastomas Correlates with Advanced Disease StageScience, 1984
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958